LINC 2021: Findings From the Promise I US Study

Published: 26 Jan 2021

  • Views:

    Views Icon 108
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Dr Peter A Schneider (University of California, San Francisco, CA, US) discusses the 12 month data from the Limflow Promise I US Early Feasibility Study. 
This pilot study assesses the safety, effectiveness and feasibility of the LimFlow Stent Graft System for creating an AV fistula in the Below The Knee (BTK) vascular system using an endovascular, minimally invasive approach for the treatment of Critical Limb Ischemia (CLI) in patients not eligible for conventional endovascular or surgical limb salvage procedures.

Recorded remotely from San Francisco, 2021.

1. Can you briefly tell us about the concept of percutaneous deep vein arterialisation (pDVA)?
2. What was the rationale for this study?
3. What was the design, patient populations and endpoints?
4. What are your findings to date and what conclusions can be made?
5. What are the next steps?

Editor: Mirjam Boros
Recording Editor: Tom Green